$CERS
Cerus Corp Stock $cers

$cers Overview Financials Valuation SEC Filings Company Website

2015 Q1 Form 10-Q Financial Statement

#000119312515179547 Filed on May 08, 2015

Income Statement

Concept	2015 Q1	2014 Q1
Revenue	$7.692M	$7.866M
YoY Change	-2.21%	-19.18%
Cost Of Revenue	$4.714M	$4.157M
YoY Change	13.4%	-18.33%
Gross Profit	$2.978M	$3.709M
YoY Change	-19.71%	-20.12%
Gross Profit Margin	38.72%	47.15%
Selling, General & Admin	$11.72M	$8.236M
YoY Change	42.28%	20.18%
% of Gross Profit	393.49%	222.05%
Research & Development	$5.581M	$4.642M
YoY Change	20.23%	71.93%
% of Gross Profit	187.41%	125.16%
Depreciation & Amortization	$443.0K	$325.0K
YoY Change	36.31%	94.61%
% of Gross Profit	14.88%	8.76%
Operating Expenses	$17.35M	$12.93M
YoY Change	34.2%	34.62%
Operating Profit	-$14.37M	-$9.219M
YoY Change	55.88%	85.87%
Interest Expense	$255.0K	$50.00K
YoY Change	410.0%	-61.83%
% of Operating Profit
Other Income/Expense, Net	$4.930M	$9.032M
YoY Change	-45.42%	-272.33%
Pretax Income	-$9.441M	-$187.0K
YoY Change	4948.66%	-98.17%
Income Tax	$19.00K	$38.00K
% Of Pretax Income
Net Earnings	-$9.460M	-$225.0K
YoY Change	4104.44%	-97.81%
Net Earnings / Revenue	-122.98%	-2.86%
Basic Earnings Per Share	-$0.10	$0.00
Diluted Earnings Per Share	-$0.17	-$0.12
COMMON SHARES
Basic Shares Outstanding	93.41M shares	72.09M shares
Diluted Shares Outstanding	94.66M shares	75.16M shares

Balance Sheet

Concept	2015 Q1	2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$111.9M	$48.30M
YoY Change	131.68%	-30.2%
Cash & Equivalents	$17.93M	$23.99M
Short-Term Investments	$94.00M	$24.30M
Other Short-Term Assets	$1.933M	$913.0K
YoY Change	111.72%	118.42%
Inventory	$16.11M	$11.31M
Prepaid Expenses	$1.331M	$1.661M
Receivables	$5.153M	$4.943M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$136.4M	$67.08M
YoY Change	103.37%	-23.29%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.797M	$3.166M
YoY Change	19.93%	98.5%
Goodwill	$1.316M	$1.316M
YoY Change	0.0%	0.0%
Intangibles	$1.092M	$1.294M
YoY Change	-15.61%	-13.5%
Long-Term Investments
YoY Change
Other Assets	$140.0K	$64.00K
YoY Change	118.75%	10.34%
Total Long-Term Assets	$6.806M	$6.148M
YoY Change	10.7%	28.97%
TOTAL ASSETS
Total Short-Term Assets	$136.4M	$67.08M
Total Long-Term Assets	$6.806M	$6.148M
Total Assets	$143.2M	$73.23M
YoY Change	95.59%	-20.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$10.51M	$3.493M
YoY Change	200.89%	-10.14%
Accrued Expenses	$7.104M	$8.838M
YoY Change	-19.62%	8.46%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$600.0K	$3.300M
YoY Change	-81.82%	-26.67%
Total Short-Term Liabilities	$22.76M	$27.23M
YoY Change	-16.41%	-1.53%
LONG-TERM LIABILITIES
Long-Term Debt	$9.300M	$0.00
YoY Change		-100.0%
Other Long-Term Liabilities	$1.116M	$1.031M
YoY Change	8.24%	-14.72%
Total Long-Term Liabilities	$1.116M	$1.031M
YoY Change	8.24%	-14.72%
TOTAL LIABILITIES
Total Short-Term Liabilities	$22.76M	$27.23M
Total Long-Term Liabilities	$1.116M	$1.031M
Total Liabilities	$33.29M	$28.36M
YoY Change	17.38%	-9.74%
SHAREHOLDERS EQUITY
Retained Earnings	-$551.4M	-$503.4M
YoY Change	9.53%	7.09%
Common Stock	$661.4M	$72.00K
YoY Change	918445.83%	2.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$109.9M	$44.87M
YoY Change
Total Liabilities & Shareholders Equity	$143.2M	$73.23M
YoY Change	95.59%	-20.58%

Cashflow Statement

Concept	2015 Q1	2014 Q1
OPERATING ACTIVITIES
Net Income	-$9.460M	-$225.0K
YoY Change	4104.44%	-97.81%
Depreciation, Depletion And Amortization	$443.0K	$325.0K
YoY Change	36.31%	94.61%
Cash From Operating Activities	-$15.75M	-$9.830M
YoY Change	60.22%	17.7%
INVESTING ACTIVITIES
Capital Expenditures	$59.00K	$839.0K
YoY Change	-92.97%	-2896.67%
Acquisitions
YoY Change
Other Investing Activities	-$65.54M	$460.0K
YoY Change	-14347.83%
Cash From Investing Activities	-$65.59M	$3.000M
YoY Change	-2286.33%	-11638.46%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$75.53M	$31.00K
YoY Change	243535.48%	-99.94%
Debt Paid & Issued, Net	$28.00K	$125.0K
YoY Change	-77.6%
Cash From Financing Activities	76.50M	1.330M
YoY Change	5651.88%	-97.38%
NET CHANGE
Cash From Operating Activities	-15.75M	-9.830M
Cash From Investing Activities	-65.59M	3.000M
Cash From Financing Activities	76.50M	1.330M
Net Change In Cash	-4.840M	-5.500M
YoY Change	-12.0%	-112.95%
FREE CASH FLOW
Cash From Operating Activities	-$15.75M	-$9.830M
Capital Expenditures	$59.00K	$839.0K
Free Cash Flow	-$15.81M	-$10.67M
YoY Change	48.18%	28.2%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q1	us-gaap	Share Price SharePrice	5.50
CY2015Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	95371010	shares
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23992000
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.22
CY2015Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	16900000	shares
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	13968000	shares
CY2015Q1	us-gaap	Secured Long Term Debt SecuredLongTermDebt	9292000
CY2015Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	0
CY2015Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	100000
CY2015Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	4189000
CY2015Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	2802000
CY2015Q1	us-gaap	Liabilities Current LiabilitiesCurrent	22764000
CY2015Q1	us-gaap	Common Stock Value CommonStockValue	95000
CY2015Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2015Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-12000
CY2015Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	10510000
CY2015Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-551404000
CY2015Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	1581000
CY2015Q1	us-gaap	Fair Value Liabilities Measured On Recurring Basis Obligations FairValueLiabilitiesMeasuredOnRecurringBasisObligations	4189000
CY2015Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	116000
CY2015Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	661258000
CY2015Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7104000
CY2015Q1	us-gaap	Stockholders Equity StockholdersEquity	109937000
CY2015Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1116000
CY2015Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	661000
CY2015Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	3003000
CY2015Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	143225000
CY2015Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	925000
CY2015Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	3364000
CY2015Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0
CY2015Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	4189000
CY2015Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	370000
CY2015Q1	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	142000
CY2015Q1	us-gaap	Liabilities Liabilities	33288000
CY2015Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2418000
CY2015Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	4000
CY2015Q1	us-gaap	Secured Debt Current SecuredDebtCurrent	591000
CY2015Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	2614000
CY2015Q1	us-gaap	Long Term Debt LongTermDebt	10000000
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17934000
CY2015Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	200000
CY2015Q1	us-gaap	Goodwill Goodwill	1316000
CY2015Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3797000
CY2015Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	99483000
CY2015Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	99471000
CY2015Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	461000
CY2015Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1092000
CY2015Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	16000
CY2015Q1	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	1400000
CY2015Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	200000
CY2015Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	13122000
CY2015Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	99483000
CY2015Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	0
CY2015Q1	us-gaap	Cost Method Investments CostMethodInvestments	0
CY2015Q1	us-gaap	Assets Assets	143225000
CY2015Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	0
CY2015Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	200000
CY2015Q1	us-gaap	Inventory Net InventoryNet	16109000
CY2015Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5153000
CY2015Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	99483000
CY2015Q1	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	93959000
CY2015Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1092000
CY2015Q1	us-gaap	Other Assets Current OtherAssetsCurrent	1933000
CY2015Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	140000
CY2015Q1	us-gaap	Assets Current AssetsCurrent	136419000
CY2015Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	99471000
CY2015Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	99471000
CY2015Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	0
CY2015Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	150000
CY2015Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	200000
CY2015Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2017000
CY2015Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2987000
CY2015Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1331000
CY2015Q1	cers	Debt Instrument Carrying Non Current DebtInstrumentCarryingNonCurrent	9363000
CY2015Q1	cers	Long Term Debt Maturities Repayments Of Principal And Interest In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestInYearFour	3227000
CY2015Q1	cers	Long Term Debt Maturities Repayments Of Interest In Year Four LongTermDebtMaturitiesRepaymentsOfInterestInYearFour	224000
CY2015Q1	cers	Outstanding Liability Related To Leasehold Improvements Current And Non Current OutstandingLiabilityRelatedToLeaseholdImprovementsCurrentAndNonCurrent	600000
CY2015Q1	cers	Debt Instrument Unamortized Noncurrent DebtInstrumentUnamortizedNoncurrent	71000
CY2015Q1	cers	Long Term Debt Maturities Repayments Of Principal And Interest Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestRemainderOfFiscalYear	522000
CY2015Q1	cers	Long Term Debt Maturities Repayments Of Principal And Interest LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterest	12517000
CY2015Q1	cers	Long Term Debt Maturities Repayments Of Interest In Year Three LongTermDebtMaturitiesRepaymentsOfInterestInYearThree	425000
CY2015Q1	cers	Long Term Debt Maturities Repayments Of Interest LongTermDebtMaturitiesRepaymentsOfInterest	2517000
CY2015Q1	cers	Finite Lived Intangible Assets Amortization Expense Year Six FiniteLivedIntangibleAssetsAmortizationExpenseYearSix	100000
CY2015Q1	cers	Long Term Debt Maturities Repayments Of Principal And Interest In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestInYearThree	3227000
CY2015Q1	cers	Cumulative Outstanding Trade Receivables Number Of Major Customers CumulativeOutstandingTradeReceivablesNumberOfMajorCustomers	1	Customer
CY2015Q1	cers	Long Term Debt Maturities Repayments Of Interest In Year Five LongTermDebtMaturitiesRepaymentsOfInterestInYearFive	733000
CY2015Q1	cers	Long Term Debt Maturities Repayments Of Interest In Year Two LongTermDebtMaturitiesRepaymentsOfInterestInYearTwo	613000
CY2015Q1	cers	Accrued Inventory AccruedInventory	11000
CY2015Q1	cers	Long Term Debt Maturities Repayments Of Principal And Interest In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestInYearTwo	3227000
CY2015Q1	cers	Long Term Debt Maturities Repayments Of Interest Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfInterestRemainderOfFiscalYear	522000
CY2015Q1	cers	Debt Instrument Unamortized Current DebtInstrumentUnamortizedCurrent	46000
CY2015Q1	cers	Long Term Debt Maturities Repayments Of Principal And Interest In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestInYearFive	2314000
CY2015Q1	cers	Leasehold Improvement Reflected In Other Non Current Liabilities LeaseholdImprovementReflectedInOtherNonCurrentLiabilities	500000
CY2015Q1	cers	Options And Other Stock Based Awards OptionsAndOtherStockBasedAwards	14100000	shares
CY2015Q1	cers	Debt Instrument Carrying Current DebtInstrumentCarryingCurrent	637000
CY2015Q1	cers	Leasehold Improvement Reflected In Accrued Liabilities LeaseholdImprovementReflectedInAccruedLiabilities	100000
CY2015Q1	cers	Accrued Customer Costs And Deposits Current AccruedCustomerCostsAndDepositsCurrent	508000
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29485000
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.13
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11323000	shares
CY2014Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	9872000
CY2014Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	0
CY2014Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	100000
CY2014Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	10485000
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	29187000
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	80000
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-31000
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	9882000
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-541944000
CY2014Q4	us-gaap	Fair Value Liabilities Measured On Recurring Basis Obligations FairValueLiabilitiesMeasuredOnRecurringBasisObligations	10485000
CY2014Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	115000
CY2014Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	583416000
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8444000
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	41521000
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1081000
CY2014Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	851000
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	81776000
CY2014Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	875000
CY2014Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2123000
CY2014Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	10485000
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	376000
CY2014Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	264000
CY2014Q4	us-gaap	Liabilities Liabilities	40255000
CY2014Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3951000
CY2014Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	0
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22781000
CY2014Q4	us-gaap	Goodwill Goodwill	1316000
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3781000
CY2014Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	33457000
CY2014Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	33426000
CY2014Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	508000
CY2014Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1142000
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	31000
CY2014Q4	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	1300000
CY2014Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	12734000
CY2014Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	27752000
CY2014Q4	us-gaap	Assets Assets	81776000
CY2014Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	5699000
CY2014Q4	us-gaap	Inventory Net InventoryNet	14956000
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5493000
CY2014Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	33457000
CY2014Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	28513000
CY2014Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1142000
CY2014Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1932000
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	144000
CY2014Q4	us-gaap	Assets Current AssetsCurrent	74885000
CY2014Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	27727000
CY2014Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	33426000
CY2014Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	5705000
CY2014Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2017000
CY2014Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2222000
CY2014Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1210000
CY2014Q4	cers	Debt Instrument Carrying Non Current DebtInstrumentCarryingNonCurrent	10000000
CY2014Q4	cers	Debt Instrument Unamortized Noncurrent DebtInstrumentUnamortizedNoncurrent	128000
CY2014Q4	cers	Cumulative Outstanding Trade Receivables Number Of Major Customers CumulativeOutstandingTradeReceivablesNumberOfMajorCustomers	1	Customer
CY2014Q4	cers	Accrued Inventory AccruedInventory	870000
CY2014Q4	cers	Debt Instrument Unamortized Current DebtInstrumentUnamortizedCurrent	0
CY2014Q4	cers	Debt Instrument Carrying Current DebtInstrumentCarryingCurrent	0
CY2014Q4	cers	Accrued Customer Costs And Deposits Current AccruedCustomerCostsAndDepositsCurrent	385000
CY2015Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	14636363	shares
CY2015Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	5100000
CY2015Q1	cers	Estimated Net Proceeds From Public Offering EstimatedNetProceedsFromPublicOffering	75400000
CY2010	cers	Proceeds From Landlord Financing Leasehold Improvement ProceedsFromLandlordFinancingLeaseholdImprovement	1100000
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2014Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	3070000	shares
CY2014Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-9825000
CY2014Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	75158000	shares
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2014Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	16901000	shares
CY2014Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	72088000	shares
CY2014Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-9259000
CY2014Q1	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0
CY2014Q1	us-gaap	Gross Profit GrossProfit	3709000
CY2014Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	7866000
CY2014Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	125000
CY2014Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	460000
CY2014Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0
CY2014Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	764000
CY2014Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1117000
CY2014Q1	us-gaap	Payments For Royalties PaymentsForRoyalties	700000
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-9219000
CY2014Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	21000
CY2014Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-225000
CY2014Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	9032000
CY2014Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-187000
CY2014Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	27000
CY2014Q1	us-gaap	Dilutive Securities DilutiveSecurities	-9034000
CY2014Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	839000
CY2014Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	0
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	-225000
CY2014Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1182000
CY2014Q1	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	0
CY2014Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	945000
CY2014Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	6000
CY2014Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	325000
CY2014Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	98000
CY2014Q1	us-gaap	Interest Expense InterestExpense	50000
CY2014Q1	us-gaap	Operating Expenses OperatingExpenses	12928000
CY2014Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8236000
CY2014Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	50000
CY2014Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-5493000
CY2014Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-9034000
CY2014Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	38000
CY2014Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	4157000
CY2014Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	1331000
CY2014Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	31000
CY2014Q1	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0
CY2014Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1295000
CY2014Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	3001000
CY2014Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	1425000
CY2014Q1	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	4642000
CY2014Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2014Q1	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0
CY2014Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2181000
CY2014Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	4300000
CY2014Q1	us-gaap	Share Based Compensation ShareBasedCompensation	946000
CY2014Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2014Q1	cers	Warrant Liability Revaluation Gain Loss WarrantLiabilityRevaluationGainLoss	9000000
CY2014Q1	cers	Payment For Manufacturing Of Entity Products PaymentForManufacturingOfEntityProducts	4600000
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2015Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.11
CY2015Q1	dei	Document Type DocumentType	10-Q
CY2015Q1	dei	Entity Registrant Name EntityRegistrantName	CERUS CORP
CY2015Q1	dei	Trading Symbol TradingSymbol	CERS
CY2015Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1251000	shares
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	2000	shares
CY2015Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2015Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-15751000
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	9000	shares
CY2015Q1	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P10Y
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2870000	shares
CY2015Q1	us-gaap	Use Of Estimates UseOfEstimates	<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Use of Estimates</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> The preparation of financial statements requires management to make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosures of contingent assets and liabilities. On an ongoing basis, management evaluates its estimates, which are based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Actual results may differ from those estimates under different assumptions or conditions.</p> </div>
CY2015Q1	dei	Document Period End Date DocumentPeriodEndDate	2015-03-31
CY2015Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	Segment
CY2015Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	5.71
CY2015Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.62
CY2015Q1	dei	Amendment Flag AmendmentFlag	false
CY2015Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2015Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
CY2015Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	94662000	shares
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
CY2015Q1	us-gaap	Guarantees Indemnifications And Warranties Policies GuaranteesIndemnificationsAndWarrantiesPolicies	<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"> <b>Guarantee and Indemnification Arrangements</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> The Company recognizes the fair value for guarantee and indemnification arrangements issued or modified by the Company. In addition, the Company monitors the conditions that are subject to the guarantees and indemnifications in order to identify if a loss has occurred. If the Company determines it is probable that a loss has occurred, then any such estimable loss would be recognized under those guarantees and indemnifications. Some of the agreements that the Company is a party to contain provisions that indemnify the counter party from damages and costs resulting from claims that the Company’s technology infringes the intellectual property rights of a third party or claims that the sale or use of the Company’s products have caused personal injury or other damage or loss. The Company has not received any such requests for indemnification under these provisions and has not been required to make material payments pursuant to these provisions.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> The Company generally provides for a one-year warranty on certain of its INTERCEPT blood-safety products covering defects in materials and workmanship. The Company accrues costs associated with warranty obligations when claims are probable. The Company has not experienced significant or systemic warranty claims nor is it aware of any existing current warranty claims and does not carry a warranty claim liability at March 31, 2015 and December 31, 2014.</p> </div>
CY2015Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.49
CY2015Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001020214
CY2015Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2015Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	13439000	shares
CY2015Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Concentration of Credit Risk</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash equivalents, short-term investments and accounts receivable.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> Pursuant to the Company’s investment policy, substantially all of the Company’s cash, cash equivalents and short-term investments are maintained at major financial institutions of high credit standing. The Company monitors the financial credit worthiness of the issuers of its investments and limits the concentration in individual securities and types of investments that exist within its investment portfolio. Generally, all of the Company’s investments carry high credit quality ratings, which is in accordance with its investment policy. At March 31, 2015, the Company does not believe there is significant financial risk from non-performance by the issuers of the Company’s cash equivalents.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> Concentrations of credit risk with respect to trade receivables exist. On a regular basis, including at the time of sale, the Company performs credit evaluations of its significant customers that it expects to sell to on credit terms. Generally, the Company does not require collateral from its customers to secure accounts receivable. To the extent that the Company determines specific invoices or customer accounts may be uncollectible, the Company establishes an allowance for doubtful accounts against the accounts receivable on its unaudited condensed consolidated balance sheets and records a charge on its unaudited condensed consolidated statements of operations as a component of selling, general and administrative expenses. At March 31, 2015 and December 31, 2014, the Company had not recorded any reserves for potentially uncollectible accounts.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> The Company had one customer that accounted for more than 10% of the Company’s outstanding trade receivables at both March 31, 2015, and December 31, 2014. This customer cumulatively represented approximately 27% and 36% of the Company’s outstanding trade receivables at March 31, 2015, and December 31, 2014, respectively. To date, the Company has not experienced collection difficulties from this customer.</p> </div>
CY2015Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	Segment
CY2015Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Reclassifications</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> Certain reclassifications have been made to prior period reported amounts to conform to the current period presentations. Previously the Company had presented the amortization of premium and accretion of any discount resulting from the purchase of fixed income securities as a component of “Interest expense” on the unaudited condensed consolidated statements of operations. The Company has reclassified approximately $0.1 million of the amortization of premium resulting from the purchase of fixed income securities as a component of “Other income, net” on the unaudited condensed consolidated statements of operations. This reclassification had no impact on net loss, total assets or total stockholders’ equity.</p> </div>
CY2015Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	214000	shares
CY2015Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	93411000	shares
CY2015Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-15756000
CY2015Q1	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-47000
CY2015Q1	us-gaap	Gross Profit GrossProfit	2978000
CY2015Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	7692000
CY2015Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	28000
CY2015Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	69982000
CY2015Q1	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	400000
CY2015Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	19000
CY2015Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	116000
CY2015Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1220000
CY2015Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-6296000
CY2015Q1	us-gaap	Payments For Royalties PaymentsForRoyalties	700000
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-14371000
CY2015Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1113000
CY2015Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9441000
CY2015Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4930000
CY2015Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-9441000
CY2015Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2000
CY2015Q1	us-gaap	Goodwill Other Changes GoodwillOtherChanges	0
CY2015Q1	us-gaap	Dilutive Securities DilutiveSecurities	-6296000
CY2015Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	59000
CY2015Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-64000
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	-9460000
CY2015Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-340000
CY2015Q1	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	0
CY2015Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1474000
CY2015Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1000
CY2015Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	443000
CY2015Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	23000
CY2015Q1	us-gaap	Interest Expense InterestExpense	255000
CY2015Q1	us-gaap	Operating Expenses OperatingExpenses	17349000
CY2015Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	11718000
CY2015Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	50000
CY2015Q1	cers	Expiration Of Non Cancelable Operating Leases Maximum Year ExpirationOfNonCancelableOperatingLeasesMaximumYear	2019
CY2015Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-4847000
CY2015Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-6296000
CY2015Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	19000
CY2015Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	4714000
CY2015Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	76498000
CY2015Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	75527000
CY2015Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2015Q1	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0
CY2015Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1488000
CY2015Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-65594000
CY2015Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	999000
CY2015Q1	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	5581000
CY2015Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2015Q1	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0
CY2015Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	484000
CY2015Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	4400000
CY2015Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1474000
CY2015Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2015Q1	cers	Safety Product Warranty Period SafetyProductWarrantyPeriod	P1Y
CY2015Q1	cers	Inventory Life Finished Goods Period InventoryLifeFinishedGoodsPeriod	P2Y
CY2015Q1	cers	Work In Process Inventory Life Period WorkInProcessInventoryLifePeriod	P1Y
CY2015Q1	cers	Warrant Liability Revaluation Gain Loss WarrantLiabilityRevaluationGainLoss	6300000
CY2015Q1	cers	Prior Written Notice Period For Termination Of Agreement PriorWrittenNoticePeriodForTerminationOfAgreement	P24M
CY2015Q1	cers	Payment For Manufacturing Of Entity Products PaymentForManufacturingOfEntityProducts	4700000
CY2015Q1	cers	Minimum Term Of Non Cancelable Operating Leases MinimumTermOfNonCancelableOperatingLeases	P1Y

Files In Submission

Name	View Source	Status
0001193125-15-179547-index-headers.html	Edgar Link	pending
0001193125-15-179547-index.html	Edgar Link	pending
0001193125-15-179547.txt	Edgar Link	pending
0001193125-15-179547-xbrl.zip	Edgar Link	pending
cers-20150331.xml	Edgar Link	completed
cers-20150331.xsd	Edgar Link	pending
cers-20150331_cal.xml	Edgar Link	unprocessable
cers-20150331_def.xml	Edgar Link	unprocessable
cers-20150331_lab.xml	Edgar Link	unprocessable
cers-20150331_pre.xml	Edgar Link	unprocessable
d901941d10q.htm	Edgar Link	pending
d901941dex101.htm	Edgar Link	pending
d901941dex102.htm	Edgar Link	pending
d901941dex311.htm	Edgar Link	pending
d901941dex312.htm	Edgar Link	pending
d901941dex321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
g901941ex10_1pg01a.jpg	Edgar Link	pending
g901941ex10_1pg01b.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CERS
Cerus Corp Stock $cers

2015 Q1 Form 10-Q Financial Statement

#000119312515179547 Filed on May 08, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CERS Cerus Corp Stock $cers

2015 Q1 Form 10-Q Financial Statement

#000119312515179547 Filed on May 08, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CERS
Cerus Corp Stock $cers